Our observation that inhibition of PKCζ expression significantly and stably reduced STAT3 activation in pancreatic cancer cells suggests that PKCζ inhibition may be a means to stably suppress STAT3 activity, and thereby enhance the sensitivity of pancreatic cancer cells to current chemotherapies. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.